Lexpos News

/Lexpos News

Class 4 Medicines Defect Information: Metronidazole 200 mg/5 ml Oral Suspension (Drugsrus Limited / Dawa Limited)

Class 4 Medicines Defect Information: Metronidazole 200 mg/5 ml Oral Suspension (Drugsrus Limited / Dawa Limited) Drug alert number: EL (23)A/19 Date issued: 23 May 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Product name:Metronidazole 200 mg/5 ml Oral Suspension, PL 30684/0236 Batch No [...]

The post Class 4 Medicines Defect Information: Metronidazole 200 mg/5 ml Oral Suspension (Drugsrus Limited / Dawa Limited) appeared first on PSNC Website.

By |May 23rd, 2023|Lexpos News|Comments Off on Class 4 Medicines Defect Information: Metronidazole 200 mg/5 ml Oral Suspension (Drugsrus Limited / Dawa Limited)

MHRA Class 4 Medicines Defect Information: Buccolam 10mg Oromucosal solution (Orifarm UK Ltd)

Class 4 Medicines Defect Information: Buccolam 10mg Oromucosal solution (Orifarm UK Ltd) Drug alert number: EL (23)A/18 Date issued: 22 May 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Product name: Buccolam 10mg Oromucosal solution (Orifarm UK Ltd) PLGB 45985/0272 Batch No Expiry Date [...]

The post MHRA Class 4 Medicines Defect Information: Buccolam 10mg Oromucosal solution (Orifarm UK Ltd) appeared first on PSNC Website.

By |May 22nd, 2023|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Information: Buccolam 10mg Oromucosal solution (Orifarm UK Ltd)

No mandatory clinical audits in 2023/34

Community pharmacy contractors are not required to undertake a contractor-chosen or an NHS England determined clinical audit in 2023/24. This follows PSNC’s request to remove this clinical governance requirement for contractors in 2023/24. A clinical audit on anticoagulants is included in the Pharmacy Quality Scheme (PQS) 2023/24. If contractors choose to not participate in PQS, [...]

The post No mandatory clinical audits in 2023/34 appeared first on PSNC Website.

By |May 22nd, 2023|Lexpos News|Comments Off on No mandatory clinical audits in 2023/34

PSNC to become Community Pharmacy England

From May 30th we will be known as Community Pharmacy England, with new branding designed to be more impactful and authoritative, helping us to better represent community pharmacy. Alongside the name change we will be starting to implement a new engagement and communications strategy to open up a better dialogue with pharmacy owners (our members). This is [...]

The post PSNC to become Community Pharmacy England appeared first on PSNC Website.

By |May 19th, 2023|Lexpos News|Comments Off on PSNC to become Community Pharmacy England

PSNC and others pledge support for wellbeing of pharmacy workforce 

PSNC and others have issued a statement on the wellbeing of the pharmacy workforce, recognising their shared endeavour to support pharmacy teams across all sectors to deliver patient care.  The Royal Pharmaceutical Society (RPS) and Pharmacist Support hosted a roundtable to discuss the impact of pharmacy workforce wellbeing on patient safety. PSNC Director of Contractor [...]

The post PSNC and others pledge support for wellbeing of pharmacy workforce  appeared first on PSNC Website.

By |May 19th, 2023|Lexpos News|Comments Off on PSNC and others pledge support for wellbeing of pharmacy workforce